Tichaona Vhembo
Tichaona Vhembo publishes mostly in Infectious Diseases, Emergency Medicine and Virology, on topics such as HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment and HIV-related health complications and treatments.
- World rank
- #2,302,938 of 7,710,434 ranked researchers
- Rank in Zimbabwe
- #413 of 1,509
- Works
- 42
- Citations
- 848
- Citations per work
- 20.2
What does Tichaona Vhembo research?
Tichaona Vhembo's work is mostly in Medicine (61%), Immunology and Microbiology (7%), Nursing (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2765.1%
- Everything else1227.6%
- Life Sciences37.3%
- 1Infectious Diseases40% of their works
- 2Emergency Medicine10% of their works
- 3Virology7% of their works
- 4Pediatrics, Perinatology and Child Health6% of their works
- 5Epidemiology6% of their works
- 6Nutrition and Dietetics4% of their works
Research topics
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- HIV-related health complications and treatments
- HIV Research and Treatment
- Tuberculosis Research and Epidemiology
- Diagnosis and treatment of tuberculosis
- Child Nutrition and Water Access
- Pneumocystis jirovecii pneumonia detection and treatment
Which keywords describe Tichaona Vhembo's research?
The keywords of their largest research topics: Antiretroviral Therapy, HIV Infection, Drug Resistance, HIV Transmission, Preexposure Prophylaxis, Integrase Inhibitors, Nucleoside Analogues and Immune Response.
- Pneumonia
- Maternal and Child Undernutrition
- Child Development
- Tuberculosis
- Treatment
- Antibodies
- Inflammation
- Cardiovascular Disease
- Immune Response
- Integrase Inhibitors
- HIV Transmission
- HIV Infection
- Antiretroviral Therapy
- Drug Resistance
- Preexposure Prophylaxis
- Nucleoside Analogues
- Vaccine
- HIV
- AIDS
- Diagnosis
- Mycobacterium tuberculosis
- Abdominal Tuberculosis
- Diagnostic Challenges
- Pneumocystis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Antiretroviral Therapy685 topics
- HIV Infection322 topics
- Drug Resistance252 topics
- HIV Transmission241 topic
- Preexposure Prophylaxis241 topic
- Integrase Inhibitors201 topic
- Nucleoside Analogues201 topic
- Immune Response142 topics
- Vaccine142 topics
- Cardiovascular Disease121 topic
- HIV122 topics
- Inflammation121 topic
- AIDS91 topic
- Antibodies91 topic
- Diagnosis82 topics
- Treatment82 topics
- Mycobacterium tuberculosis51 topic
- Tuberculosis51 topic
- Abdominal Tuberculosis41 topic
- Child Development41 topic
- Diagnostic Challenges41 topic
- Maternal and Child Undernutrition41 topic
- Pneumocystis31 topic
- Pneumonia31 topic
Where does Tichaona Vhembo work?
Tichaona Vhembo's main affiliation in the publication record is University of Zimbabwe, Zimbabwe.
How many publications and citations does Tichaona Vhembo have?
OpenAlex counts 42 works and 848 citations for Tichaona Vhembo, an h-index of 15, ranking #2,302,938 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tichaona Vhembo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.